Vincent Lin

Counsel

Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.

pdf

Vincent Lin focuses his practice on capital markets, private and public securities offerings, venture capital/private equity financings, mergers and acquisitions, and corporate governance.

Vincent has advised numerous issuers listed on the NYSE, Nasdaq, and the Hong Kong Stock Exchange on compliance and regulatory matters. His clients include eHi Car Services Limited, Montage Technology Group Limited, Giant Interactive Group Inc., Acorn International, Inc., China Kanghui Holdings, Christine International Limited, and Shanghai Haohai Biotechnology Limited.

Prior to joining O’Melveny, Vincent worked as an associate for international law firms in Hong Kong and Taipei, Taiwan.

Languages

  • Mandarin Chinese
  • Taiwanese

Admissions

Bar Admissions

  • New York
  • Taiwan

Education

  • Columbia University, LL.M.,  2006
  • Chuang Yuan Christian University, LL.M., 2002
  • National Taiwan University, LL.B., 2000

Professional Activities

Members

  • Taipei, New York City, New York State, and American Bar Associations

Initial Public Offerings

  • Pharmaron in its approximately US$588 million dual primary listing and H share offering in Hong Kong
  • Shanghai Kindly Medical Instrument Co., Ltd., in its US$106 million IPO and listing on the Hong Kong Stock Exchange
  • Viva Biotech (1873.HK) in its HK$1,521.5 million (approximately US$194 million) IPO and listing on the Hong Kong Stock Exchange
  • Shanghai Haohai Biological (6826.HK) in its US$300 million IPO and listing on the Hong Kong Stock Exchange
  • eHi Car Services Limited in its US$120 million IPO on the NYSE
  • China Kanghui Holdings (NYSE: KH) in its US$78.7 million IPO and listing on the NYSE
  • Montage Technology Group Limited (NASDAQ: MONT) in its US$81.7 million IPO and listing on NASDAQ
  • LifeTech Scientific Corporation (8122.HK) in its HK$283 million IPO and listing on the Hong Kong Stock Exchange
  • Christine International Holdings Ltd. (1210.HK) in its HK$400 million IPO and listing on the Hong Kong Stock Exchange
  • China Lifestyle Food & Beverages Group Ltd. in its IPO and listing on the Hong Kong Stock Exchange
  • GCL-Poly Energy Holdings Ltd. in its IPO and listing on the Hong Kong Stock Exchange
  • Giant Interactive Group Inc. in its follow-on offering on the New York Stock Exchange
VIEW MORE